Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CSWYY

China Shineway Pharmaceutical Group Limited

USD

Set alert

Price alert · CSWYY

All alert types
16.79 USD 0.00 0.00%
As of Oct 29, 2026
16.82 Day range 16.82
16.79 52-week range 21.49
YTD
-12.78%
1 year
-12.78%
Open
16.82
Prev close
16.79
Mkt cap
634.16M
Vol
1
Avg vol
36
EPS
3.06
P/E
5.49
More statistics
Low
16.82
High
16.82

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CSWYY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.31 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 3
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 4
  • P/E 4
  • P/B 5

Valuation

P/E 0.3×
FY 2016: 0.5×FY 2017: 0.7×FY 2018: 0.6×FY 2019: 0.6×FY 2020: 0.9×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
P/S 0.1×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
P/B 0.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/FCF 0.3×
FY 2016: 0.5×FY 2017: 0.7×FY 2018: 0.8×FY 2019: 1.1×FY 2020: 0.5×FY 2021: 0.4×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
EV/EBITDA -9.0×
FY 2016: -4.6×FY 2017: -7.3×FY 2018: -5.9×FY 2019: -3.8×FY 2020: -5.3×FY 2021: -4.3×FY 2022: -4.4×FY 2023: -3.8×FY 2024: -4.5×FY 2025: -9.0×
FY 2016 5y median -4.4× FY 2025
EV/Sales -2.2×
FY 2016: -1.4×FY 2017: -1.7×FY 2018: -1.3×FY 2019: -1.2×FY 2020: -1.2×FY 2021: -1.2×FY 2022: -1.2×FY 2023: -1.2×FY 2024: -1.5×FY 2025: -2.2×
FY 2016 5y median -1.2× FY 2025
FCF Yield 383.2%
FY 2016: 200.6%FY 2017: 134.0%FY 2018: 130.5%FY 2019: 93.0%FY 2020: 209.7%FY 2021: 229.7%FY 2022: 620.9%FY 2023: 312.8%FY 2024: 322.2%FY 2025: 383.2%
FY 2016 5y median 322.2% FY 2025

Profitability

Gross Margin 72.3%
FY 2016: 61.7%FY 2017: 66.0%FY 2018: 73.0%FY 2019: 73.2%FY 2020: 74.9%FY 2021: 75.8%FY 2022: 73.1%FY 2023: 75.1%FY 2024: 75.0%FY 2025: 72.3%
FY 2016 5y median 75.0% FY 2025
Operating Margin 21.8%
FY 2016: 28.3%FY 2017: 20.8%FY 2018: 19.2%FY 2019: 17.6%FY 2020: 15.0%FY 2021: 16.6%FY 2022: 18.1%FY 2023: 21.6%FY 2024: 22.3%FY 2025: 21.8%
FY 2016 5y median 21.6% FY 2025
Net Margin 30.3%
FY 2016: 28.3%FY 2017: 23.5%FY 2018: 19.7%FY 2019: 18.6%FY 2020: 11.1%FY 2021: 17.5%FY 2022: 18.0%FY 2023: 21.5%FY 2024: 22.2%FY 2025: 30.3%
FY 2016 5y median 21.5% FY 2025
ROE 11.5%
FY 2016: 10.5%FY 2017: 7.8%FY 2018: 8.8%FY 2019: 8.7%FY 2020: 5.1%FY 2021: 9.4%FY 2022: 11.3%FY 2023: 13.8%FY 2024: 11.3%FY 2025: 11.5%
FY 2016 5y median 11.3% FY 2025
ROIC 5.8%
FY 2016: 9.1%FY 2017: 5.3%FY 2018: 6.5%FY 2019: 5.9%FY 2020: 4.7%FY 2021: 6.7%FY 2022: 8.8%FY 2023: 10.2%FY 2024: 7.8%FY 2025: 5.8%
FY 2016 5y median 7.8% FY 2025
ROA 8.6%
FY 2016: 9.1%FY 2017: 6.8%FY 2018: 7.5%FY 2019: 7.1%FY 2020: 4.1%FY 2021: 7.7%FY 2022: 8.8%FY 2023: 10.1%FY 2024: 8.4%FY 2025: 8.6%
FY 2016 5y median 8.6% FY 2025

Growth (YoY)

Revenue -19.3%
FY 2016: 1.5%FY 2017: -7.9%FY 2018: 33.9%FY 2019: 5.3%FY 2020: -1.9%FY 2021: 19.8%FY 2022: 26.3%FY 2023: 12.4%FY 2024: -16.4%FY 2025: -19.3%
FY 2016 FY 2025
Operating Income -21.3%
FY 2016: -6.8%FY 2017: -32.6%FY 2018: 24.1%FY 2019: -3.6%FY 2020: -16.2%FY 2021: 32.1%FY 2022: 37.7%FY 2023: 34.4%FY 2024: -13.6%FY 2025: -21.3%
FY 2016 FY 2025
EPS (diluted) 10.2%
FY 2016: -11.3%FY 2017: -22.5%FY 2018: 12.7%FY 2019: 3.2%FY 2020: -39.1%FY 2021: 89.7%FY 2022: 29.7%FY 2023: 33.7%FY 2024: -13.5%FY 2025: 10.2%
FY 2016 FY 2025
Free Cash Flow 18.4%
FY 2016: -0.1%FY 2017: -37.4%FY 2018: 1.6%FY 2019: -31.0%FY 2020: 104.8%FY 2021: 6.5%FY 2022: 60.8%FY 2023: -19.6%FY 2024: 4.4%FY 2025: 18.4%
FY 2016 FY 2025

Financial Health

Current Ratio 3.7×
FY 2016: 6.3×FY 2017: 6.4×FY 2018: 6.0×FY 2019: 4.4×FY 2020: 4.6×FY 2021: 5.2×FY 2022: 4.1×FY 2023: 3.4×FY 2024: 3.5×FY 2025: 3.7×
FY 2016 5y median 3.7× FY 2025
Quick Ratio 3.4×
FY 2016: 5.9×FY 2017: 6.0×FY 2018: 5.4×FY 2019: 4.1×FY 2020: 4.2×FY 2021: 4.7×FY 2022: 3.7×FY 2023: 3.0×FY 2024: 3.2×FY 2025: 3.4×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -9.3×
FY 2016: -5.1×FY 2017: -8.0×FY 2018: -6.5×FY 2019: -4.2×FY 2020: -5.7×FY 2021: -4.6×FY 2022: -4.5×FY 2023: -3.9×FY 2024: -4.7×FY 2025: -9.3×
FY 2016 5y median -4.6× FY 2025
Interest Coverage 120×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 179×FY 2020: 25.4×FY 2021: 421×FY 2022: 1153×FY 2023: 356×FY 2024: 137×FY 2025: 120×
FY 2016 5y median 356× FY 2025

Dividends

Dividend Yield 139.7%
FY 2016: 83.3%FY 2017: 88.9%FY 2018: 84.1%FY 2019: 82.8%FY 2020: 88.4%FY 2021: 170.7%FY 2022: 153.1%FY 2023: 125.9%FY 2024: 159.7%FY 2025: 139.7%
FY 2016 5y median 153.1% FY 2025
Payout Ratio 38.4%
FY 2016: 44.9%FY 2017: 58.6%FY 2018: 51.6%FY 2019: 49.5%FY 2020: 81.8%FY 2021: 81.4%FY 2022: 33.4%FY 2023: 32.7%FY 2024: 48.6%FY 2025: 38.4%
FY 2016 5y median 38.4% FY 2025

Annual · latest fiscal year ends 2025-12-31